Jing Wang
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 21, 2024
Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer.Fen Xiao, ZhiBin Wang, Liu Qiao
|May 27, 2024
Progesterone Enhances Niraparib Efficacy in Ovarian Cancer by Promoting Palmitoleic-Acid-Mediated Ferroptosis.Nayiyuan Wu, Xiu Zhang, Chao Fang
|Apr 15, 2024
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy.Zhi-Bin Wang, Xiu Zhang, Chao Fang
|Feb 19, 2024
Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.Hanmei Lou, Hongbing Cai, Xin Huang
|Jun 22, 2020
PARP inhibitor resistance: the underlying mechanisms and clinical implications.He Li, Zhao-Yi Liu, Nayiyuan Wu
Pageof 1
Frequent Collaborators
1 joint publications
Hanmei Lou
1 joint publications
Hongbing Cai
1 joint publications
Xin Huang
1 joint publications
Guiling Li
1 joint publications
Li Wang
1 joint publications
Fei Liu
1 joint publications
Wenjing Qin
1 joint publications
Ting Liu
1 joint publications
Wei Liu
1 joint publications
Zhongmin Maxwell Wang
